Method For Prediction Of Effectiveness Of Rar- Agonist

  • Published: Jul 30, 2008
  • Earliest Priority: Oct 24 2005
  • Family: 12
  • Cited Works: 0
  • Cited by: 0
  • Cites: 0
  • Sequences: 8
  • Additional Info: Published Sequence
Full-text?

The full document isn't yet available to us from the patent office.

Abstract

A method for predicting preventive and/or therapeutic effect of an RAR- ± agonist on a malignant tumor, which comprises the steps of measuring an expression level of a class of p160 family molecule and an expression level of a class of SP110 family molecule in a sample collected from the malignant tumor of a patient, and when the class of the p160 family molecule is dominant in a balance between the expression level of the class of the p160 family molecule and the expression level of the class of the SP110 family molecule, determining that an RAR- ± agonist is effective for therapeutic treatment of the malignant tumor of the patient.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jul 30, 2008
  • Application: Oct 23, 2006
    EP EP 06822051 A
  • Priority: Oct 23, 2006
    JP 2006321031 W
  • Priority: Jun 27, 2006
    US US 81661606 P
  • Priority: Oct 24, 2005
    US US 72917505 P

Download Citation


Sign in to the Lens

Feedback